To increase translational relevance, we examined tau pathology and levels of synaptic tau-interacting proteins in AD brain tissue and found increased indications of tau spread and elevated SYNGR3 in AD patients with a clinical seizure history compared to those without. This evidence concerns the gene MAPT and Alzheimer disease.